RWPA
SNY icon

Richard W. Paul & Associates’s Sanofi SNY Stock Holding History

Richard W. Paul & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9K Buy
700
+64
+10% +$2.86K 0.01% 190
2026
Q1 		$30.6K Buy
636
+151
+31% +$7.04K 0.01% 188
2025
Q4 		$23.5K Sell
485
-3
-0.6% -$149 0.01% 194
2025
Q3 		$23K Buy
488
+2
+0.4% +$97 0.01% 197
2025
Q2 		$23.5K Buy
486
+4
+0.8% +$204 0.01% 212
2025
Q1 		$26.7K Sell
482
-60
-11% -$3.25K 0.01% 204
2024
Q4 		$26.1K Buy
542
+2
+0.4% +$102 0.01% 233
2024
Q3 		$31.1K Buy
540
+1
+0.2% +$54 0.01% 232
2024
Q2 		$26.2K Buy
539
+117
+28% +$5.64K 0.01% 234
2024
Q1 		$20.5K Buy
422
+105
+33% +$5.13K 0.01% 263
2023
Q4 		$15.8K Sell
317
-111
-26% -$5.43K 0.01% 272
2023
Q3 		$23K Sell
428
-21
-5% -$1.12K 0.01% 239
2023
Q2 		$24.2K Buy
449
+65
+17% +$3.5K 0.01% 256
2023
Q1 		$20.9K Buy
384
+261
+212% +$12.7K 0.01% 264
2022
Q4 		$5.96K Buy
+123
New +$5.4K ﹤0.01% 360

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Richard W. Paul & Associates's SNY Position: Q2 2026 in Review

Richard W. Paul & Associates increased its Sanofi (SNY) stake by 10% in Q2 2026, buying an estimated $2.86K and bringing the position to 700 shares worth $29.9K. The position accounts for 0.01% of the portfolio, ranked #190.

Richard W. Paul & Associates first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $31.1K in Q3 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Richard W. Paul & Associates held 700 shares of Sanofi worth $29.9K as of Q2 2026.
  • Richard W. Paul & Associates bought 64 Sanofi shares in Q2 2026, an estimated $2.86K.
  • Sanofi made up 0.01% of Richard W. Paul & Associates's portfolio in Q2 2026, its #190 holding.
  • Richard W. Paul & Associates first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • Richard W. Paul & Associates's Sanofi position peaked at $31.1K in Q3 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.